Epidemiology of pertussis in Italy: disease trends over the last century.

We reviewed the epidemiology of pertussis in Italy over the last 125 years to identify disease trends and factors that could have influenced these trends. We described mortality rates (1888-2012), case fatality rates (1925-2012), cumulative incidence rates (1925-2013) and age-specific incidence rates (1974-2013). We compared data from routine surveillance with data from a paediatric sentinel surveillance system to estimate under-notification. Pertussis mortality decreased from 42.5 per 100,000 population in 1890 to no reported pertussis-related death after 2002. Incidence decreased from 86.3 per 100,000 in 1927 to 1 per 100,000 after 2008. Vaccine coverage increased from 32.8% in 1993 to about 96% after 2006. As for under-notification, mean sentinel/routine surveillance incidence ratio increased with age (from 1.8 in <1 year-olds to 12.9 in 10-14 year-olds). Pertussis mortality decreased before the introduction of immunisation. Incidence has decreased only after the introduction of pertussis vaccine and in particular after the achievement of a high immunisation coverage with acellular vaccines. Routine surveillance does not show an increase in cumulative incidence nor in ≥ 15 year-olds as reported by other countries. Underrecognition because of atypical presentation and the infrequent use of laboratory tests may be responsible for under-notification, and therefore affect incidence reports and management of immunisation programmes.

[1]  S. Salmaso,et al.  Immunization coverage in Italy. , 1987, Bulletin of the World Health Organization.

[2]  S. Salmaso,et al.  Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience. , 1992, The Pediatric infectious disease journal.

[3]  S. Salmaso,et al.  Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. ICONA Study Group. , 1999, Bulletin of the World Health Organization.

[4]  S. Salmaso,et al.  Pediatric sentinel surveillance of vaccine-preventable diseases in Italy , 2002, The Pediatric infectious disease journal.

[5]  Masahiro Tanaka,et al.  Trends in pertussis among infants in the United States, 1980-1999. , 2003, JAMA.

[6]  L. Ravà,et al.  Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. , 2003, Pediatrics.

[7]  Aaron M Wendelboe,et al.  Duration of Immunity Against Pertussis After Natural Infection or Vaccination , 2005, The Pediatric infectious disease journal.

[8]  M. Massari,et al.  How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy. , 2005, Vaccine.

[9]  M. Massari,et al.  Resurgence of Pertussis in Europe , 2005, The Pediatric infectious disease journal.

[10]  D. Bernstein,et al.  Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  V. Boddi,et al.  Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy , 2008, Epidemiology and Infection.

[12]  M. Littmann,et al.  The epidemiology of pertussis in Germany: past and present , 2009, BMC infectious diseases.

[13]  P. Rohani,et al.  Estimating the Duration of Pertussis Immunity Using Epidemiological Signatures , 2009, PLoS pathogens.

[14]  C. Mathers,et al.  Global, regional, and national causes of child mortality in 2008: a systematic analysis , 2010, The Lancet.

[15]  P. Spokes,et al.  NSW Annual Vaccine-Preventable Disease Report, 2009. , 2010, New South Wales public health bulletin.

[16]  J. Drake,et al.  The decline and resurgence of pertussis in the US. , 2011, Epidemics.

[17]  Ken Eames,et al.  "Herd immunity": a rough guide. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  T. Clark,et al.  Pertussis control: time for something new? , 2012, Trends in microbiology.

[19]  Bruce Fireman,et al.  Waning protection after fifth dose of acellular pertussis vaccine in children. , 2012, The New England journal of medicine.

[20]  T. Clark,et al.  Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. , 2012, JAMA.

[21]  A. Rosewell,et al.  NSW Annual vaccine-preventable disease report, 2011. , 2012, New South Wales public health bulletin.

[22]  M. Witt,et al.  Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  A. Tozzi,et al.  Attitude of Italian physicians toward pertussis diagnosis , 2013, Human vaccines & immunotherapeutics.

[24]  P. Rohani,et al.  Perplexities of pertussis: recent global epidemiological trends and their potential causes , 2013, Epidemiology and Infection.

[25]  G. Amirthalingam,et al.  Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  R. Pebody,et al.  Incidence of pertussis in patients of general practitioners in Poland , 2013, Epidemiology and Infection.